Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 2
1949 1
1950 1
1951 1
1954 1
1955 1
1957 1
1960 1
1963 2
1965 2
1966 2
1968 2
1969 1
1972 2
1973 1
1975 5
1976 5
1977 2
1978 8
1979 4
1980 1
1981 5
1982 9
1983 2
1984 3
1985 12
1986 4
1987 6
1988 7
1989 7
1990 5
1991 5
1992 5
1993 10
1994 11
1995 3
1996 10
1997 5
1998 8
1999 6
2000 10
2001 4
2002 11
2003 6
2004 7
2005 8
2006 10
2007 16
2008 15
2009 20
2010 20
2011 15
2012 11
2013 25
2014 29
2015 33
2016 29
2017 18
2018 32
2019 31
2020 38
2021 48
2022 51
2023 9
Text availability
Article attribute
Article type
Publication date

Search Results

610 results
Results by year
Filters applied: . Clear all
Page 1
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.
Hodgson DR, Dougherty BA, Lai Z, Fielding A, Grinsted L, Spencer S, O'Connor MJ, Ho TW, Robertson JD, Lanchbury JS, Timms KM, Gutin A, Orr M, Jones H, Gilks B, Womack C, Gourley C, Ledermann J, Barrett JC. Hodgson DR, et al. Among authors: orr m. Br J Cancer. 2018 Nov;119(11):1401-1409. doi: 10.1038/s41416-018-0274-8. Epub 2018 Oct 24. Br J Cancer. 2018. PMID: 30353044 Free PMC article. Clinical Trial.
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott CL, Meier W, Shapira-Frommer R, Safra T, Matei D, Fielding A, Spencer S, Dougherty B, Orr M, Hodgson D, Barrett JC, Matulonis U. Ledermann J, et al. Among authors: orr m. Lancet Oncol. 2014 Jul;15(8):852-61. doi: 10.1016/S1470-2045(14)70228-1. Epub 2014 May 31. Lancet Oncol. 2014. PMID: 24882434 Clinical Trial.
Regreening: green is not always gold.
Orr MC, Hughes AC. Orr MC, et al. Nature. 2022 Apr;604(7904):40. doi: 10.1038/d41586-022-00944-4. Nature. 2022. PMID: 35383325 No abstract available.
610 results